Brainomix and Pulmonary Fibrosis Foundation Partner to Bring Patient Perspectives to AI-Powered Pulmonary Fibrosis Care

Brainomix, a leading medtech company specializing in AI-powered imaging tools for lung disease and stroke, today announced a new partnership with the Pulmonary Fibrosis Foundation (PFF) to bring the voices of patients and caregivers into exploring how AI-powered imaging could support the care of people living with pulmonary fibrosis (PF) and other fibrotic interstitial lung diseases (ILD).

The partnership will focus on understanding patients' perspectives when e-Lung quantitative CT analysis is incorporated into clinicians' assessment workflow. The research will explore how access to objective quantitative CT metrics could enhance clinicians' understanding of changes in disease over time, while examining how these insights are experienced and understood by patients. The initiative will also explore how these imaging insights could support more informed conversations between patients and their healthcare teams, including discussions around treatment decisions.